SCHEMBL783749

SCHEMBL783749

O=C(O)c1cccc2c1oc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
ALOX5 P09917 2/20 0.49
DHODH Q02127 1/20 0.47
PTPRF P10586 5/20 0.47
PTPN2 P17706 5/20 0.47
PTPN1 P18031 5/20 0.47
ALDH1A1 P00352 2/20 0.46
ALOX15 P16050 1/20 0.46
KDM4E B2RXH2 1/20 0.46
USP2 O75604 1/20 0.46
CSNK2A2 P19784 1/20 0.46
PTGS1 P23219 1/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
CSNK2A3 Q8NEV1 1/20 0.46
MAOB P27338 1/20 0.46
MAOA P21397 1/20 0.46
GPR35 Q9HC97 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382080 0.88 MAOA (0.63) ALDH1A1KDM4EMAOBMAOATBK1
SCHEMBL18854814 0.86 ALOX5 (0.55) NR4A1NR4A2NR4A3ALOX5KDM4E
SCHEMBL69699 0.86 NR4A1 (0.54) NR4A1NR4A2NR4A3DHODHPTPRF
SCHEMBL22645256 0.84 MAPT (0.51) ALOX5PTPN1ALDH1A1MAOBMAOA
SCHEMBL4586057 0.84 ALOX5 (0.48) ALOX5ALDH1A1ALOX15KDM4EMAOA
SCHEMBL28084237 0.84 ALDH1A1 (0.59) ALOX5ALDH1A1KDM4EUSP2CSNK2A2
SCHEMBL14825579 0.84 ALOX5 (0.48) ALOX5ALDH1A1KDM4EMAOBMAOA
SCHEMBL20793652 0.83 GPR35 (0.51) NR4A1NR4A2NR4A3ALDH1A1ALOX15
SCHEMBL10949940 0.82 HSD17B10 (0.50) NR4A1NR4A2NR4A3DHODHPTPRF
SCHEMBL11554090 0.82 PTPN1 (0.60) PTPRFPTPN2PTPN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550587-A1 STEREOSELECTIVE PREPARATION OF ACID SENSITIVE AMIDES AND INTERMEDIATES USEFUL IN SAID PREPARATION RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1993-07-14 EP claimed
WO-1992005146-A1 STEREOSELECTIVE PREPARATION OF ACID SENSITIVE AMIDES AND INTERMEDIATES USEFUL IN SAID PREPARATION RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-04-02 WO claimed
US-5086179-A Process for the preparation of optically pure amides RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-02-04 US claimed
JP-9263558-A None JP disclosed
US-20250136584-A1 Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof CHENGDU DI'AO JIUHONG PHARMACEUTICAL FACTORY (CN) 2025-05-01 US disclosed
EP-4467538-A1 BENZIMIDAZOLE OR AZABENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Chengdu Di'Ao Jiuhong Pharmaceutical Factory (CN) 2024-11-27 EP disclosed
CN-118955479-A Benzimidazole or azabenzimidazole compound, preparation method and application thereof 成都地奥九泓制药厂 2024-11-15 CN disclosed
CN-116574092-B Benzimidazole or azabenzimidazole compound, preparation method and application thereof 成都地奥九泓制药厂 2024-08-20 CN disclosed
US-20240224781-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-07-04 US disclosed
CN-117801022-A Organic electroluminescent material and device 环球展览公司 2024-04-02 CN disclosed
WO-2023222084-A1 BENZIMIDAZOLE OR AZABENZIMIDAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 成都地奥九泓制药厂 2023-11-23 WO disclosed
EP-0494140-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1992-07-15 EP disclosed
WO-1992009592-A1 PROCESS FOR PREPARING MULTICYCLIC OXY-CONTAINING RING COMPONENTS RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-06-11 WO disclosed
WO-1992005146-A1 STEREOSELECTIVE PREPARATION OF ACID SENSITIVE AMIDES AND INTERMEDIATES USEFUL IN SAID PREPARATION RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-04-02 WO disclosed
US-5086179-A Process for the preparation of optically pure amides RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1992-02-04 US disclosed
WO-1991004738-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-04-18 WO disclosed
US-4959485-A 5-HT3 ANTAGONISTS RORER PHARMACEUTICAL CORPORATION (US) 1990-09-25 US disclosed
WO-1989010364-A1 DIBENZOFURANCARBOXAMIDES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-11-02 WO disclosed
EP-0339950-A2 Dibenzofurancarboxamides, their use as pharmaceutical agents, a composition containing the same, and a process for the preparation thereof RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-11-02 EP disclosed
US-4863921-A Dibenzofurancarboxamides and their pharmaceutical compositions and methods RORER PHARMACEUTICAL CORPORATION (US) 1989-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240224781-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES MLX, LOXL1, SSB NR4A1 751/4885NR4A2 979/4885NR4A3 1080/4885
US-20250136584-A1 Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof GLP1R, GIPR, SLC5A1 NR4A1 839/4885NR4A2 1965/4885NR4A3 1733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.